Frazier Life Sciences Public Fund, L.P. 13D and 13G filings for Eledon Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 11:22 am Sale |
2024-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
Frazier Life Sciences Public Fund, L.P. | 1,176,735 2.000% |
-2,384,909 (-66.96%) |
Filing |
| 2024-11-05 11:44 am Purchase |
2024-10-30 | 13G | Eledon Pharmaceuticals, Inc. ELDN |
Frazier Life Sciences Public Fund, L.P. | 3,561,644 6.100% |
3,561,644 (New Position) |
Filing |